AT
Aptevo Therapeutics Inc
🇺🇸XNAS.APVOUnited StatesHealthcare
$1.82USDup +0.02 (+1.11%)OpenEnd of day5:57 PM
Price$1.82+0.02 (+1.11%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US03835L2079
- CUSIP
- 03835L207
Company
- Employees
- 33
- Headquarters
- Seattle, United States
- CEO
- Mr. Jeffrey G. Lamothe CA
Market
- Shares outstanding
- 1.8M
- Market cap
- $3.29M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $3.29M
- EPS LTM
- -$22.07
- P/E LTM
- -0.20
- Div yield
- 31.4%
Fundamentals (LTM)
- Revenue
- -$220K-100%down year on year
- Net income
- -$26.41M-9.92%down year on year
- Gross margin
- 175%
- Free cash flow
- -$25.34M-2.82%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.